"Metastatic breast cancer is where breast cancer moves from the origin in the breast through the blood, and through the lymph ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

Cancer metabolism is a critical area of research, central to understanding how malignant tumors manipulate metabolic pathways to support their growth and survival. These alterations not only fuel ...

Oncobone Ventures Ltd. and Origenis GmbH have signed a framework agreement to develop novel therapies targeting cancer bone metastasis. Origenis leverages its artificial intelligence (AI)-driven ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Linda Chavez, 34, was diagnosed with Metastatic Bronchial Carcinoma, which has spread to her brain and bones. She regularly ...

ZetaMet™ (Zeta-BC-003) is a synthetic, small-molecule, delivered via a proprietary controlled- release carrier intended to resolve metastatic breast cancer bone lesions, inhibit pain while ...

All the time in the world is never enough time. You especially notice this when you don't know if you'll get another day.

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

The "Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 10+ ...